» Articles » PMID: 38474281

Functional Variants Are Differentially Associated with Immune-Mediated Inflammatory Diseases

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2024 Mar 13
PMID 38474281
Authors
Affiliations
Soon will be listed here.
Abstract

As the principal ligand for NKG2D, MICA elicits the recruitment of subsets of T cells and NK cells in innate immunity. MICA gene variants greatly impact the functionality and expression of MICA in humans. The current study evaluated whether polymorphisms distinctively influence the pathogenesis of psoriasis (PSO), rheumatoid arthritis (RA), and systemic lupus erythematosus (SLE) in Taiwanese subjects. The distributions of alleles and levels of serum soluble NKG2D were compared between healthy controls and patients with PSO, RA, and SLE, respectively. The binding capacities and cell surface densities of MICA alleles were assessed by utilizing stable cell lines expressing four prominent Taiwanese alleles. Our data revealed that *010 was significantly associated with risks for PSO and RA (P = 1.93 × 10 and 0.00112, respectively), while *045 was significantly associated with predisposition to SLE (P = 0.0002). On the other hand, *002 was associated with protection against RA development (P = 4.16 × 10), while *009 was associated with a low risk for PSO (P = 0.0058). *002 exhibited the highest binding affinity for NKG2D compared to the other alleles. Serum concentrations of soluble MICA were significantly elevated in SLE patients compared to healthy controls ( = 0.01). The lack of cell surface expression of the *010 was caused by its entrapment in the endoplasmic reticulum. As a prevalent risk factor for PSO and RA, *010 is deficient in cell surface expression and is unable to interact with NKG2D. Our study suggests that alleles distinctively contribute to the pathogenesis of PSO, RA, and SLE in Taiwanese people.

Citing Articles

and gene polymorphisms influence graft survival, and response to therapy in kidney transplantation.

Littera R, Mocci S, Argiolas D, Littarru L, Lai S, Melis M Front Immunol. 2024; 15:1440887.

PMID: 39575256 PMC: 11578996. DOI: 10.3389/fimmu.2024.1440887.

References
1.
Boukouaci W, Al-Daccak R, Dulphy N, Lauden L, Amokrane K, Fortier C . Soluble MICA-NKG2D interaction upregulates IFN-γ production by activated CD3-CD56+ NK cells: potential impact on chronic graft versus host disease. Hum Immunol. 2013; 74(12):1536-41. DOI: 10.1016/j.humimm.2013.08.281. View

2.
Kirsten H, Petit-Teixeira E, Scholz M, Hasenclever D, Hantmann H, Heider D . Association of MICA with rheumatoid arthritis independent of known HLA-DRB1 risk alleles in a family-based and a case control study. Arthritis Res Ther. 2009; 11(3):R60. PMC: 2714103. DOI: 10.1186/ar2683. View

3.
Wielinska J, Tarassi K, Iwaszko M, Koscinska K, Wysoczanska B, Mole E . Shared epitope and polymorphism of and encoding genes in Greek and Polish patients with rheumatoid arthritis. Cent Eur J Immunol. 2021; 46(1):92-98. PMC: 8056341. DOI: 10.5114/ceji.2021.104425. View

4.
Zou Y, Stastny P . Role of MICA in the immune response to transplants. Tissue Antigens. 2010; 76(3):171-6. DOI: 10.1111/j.1399-0039.2010.01527.x. View

5.
Yoshida K, Komai K, Shiozawa K, Mashida A, Horiuchi T, Tanaka Y . Role of the MICA polymorphism in systemic lupus erythematosus. Arthritis Rheum. 2011; 63(10):3058-66. DOI: 10.1002/art.30501. View